申请人:Gidwani Ramesh Matioram
公开号:US20120184617A1
公开(公告)日:2012-07-19
The invention relates to a process for producing pharmaceutically acceptable salts of fingolimod (I), comprising the step of reacting N-[1,1-bis hydroxymethyl-3-(4-octyl phenyl)-propyl]-acylamide (II) with an acidic compound. Furthermore, the invention provides different pharmaceutically acceptable salts of fingolimod and a polymorphic form of fingolimod hydrochloride.
本发明涉及一种制备盐酸非洛松的药用可接受盐的过程,包括将N-[1,1-双羟甲基-3-(4-辛基苯基)-丙基]-酰胺(II)与酸性化合物反应的步骤。此外,本发明提供了不同的药用可接受盐和非洛松盐酸盐的多晶形式。